Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LF-PB for Seroma Prevention in Breast Cancer ALND
NCT02668588Phase 2Completed
- Sponsor
- Chemi S.p.A.
- Start
- Oct 2015
- Primary completion
- Jul 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of Octreotide long-acting injection in Seroma, sponsored by Chemi S.p.A.. Started Oct 2015; status: completed.
02
Drugs
Octreotide long-acting injection
03
Conditions
Seroma
Beyond the preview
Go deeper on NCT02668588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02668588.